Greg Barritt joined the Department of Medical Biochemistry at Flinders University as a Lecturer in 1976; continuing as Senior Lecturer, Associate Professor and Professor at Flinders University with concurrent responsibilities in teaching (medical and science courses), research and administration. Greg was involved in establishing the Flinders Medical Research Institute and Flinders Institute for Health Research. He was Research Director of the Flinders Medical Research Institute (1999 – 2004) and Head of Medical Biochemistry Discipline, Flinders Medical Science and Technology (2005-2013). Currently he is an Emeritus Professor.

Research conducted in Emeritus Barritt’s laboratory has made a substantial contribution to new knowledge of the roles of intracellular Ca²⁺ as a second messenger, store-operated Ca²⁺ channels, TRP channels, inositol 1,4,5-trisphosphate and diacylglycerol in intracellular signalling in liver and prostate cancer cells. Significant contributions have also been made to the understand of the roles of intracellular Ca²⁺ and reactive oxygen species in liver ischemia reperfusion injury. His laboratory is acknowledged internationally as a leader in studies of the structure and function of plasma membrane Ca²⁺ channels, Ca²⁺ signalling in liver cells and TRP channels in prostate cancer cells.